ADAG Stock Analysis: Buy, Sell, or Hold?
ADAG - Adagene Inc. American Depositary Shares
$2.85
-0.09 (-3.23%)
▼
5d:
+14.26%
30d:
+54.62%
90d:
+59.83%
HOLD
MODERATE Confidence
Last Updated: February 3, 2026
Earnings: Mar 23, 2026
Get Alerted When ADAG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: ADAG is 12.9% above fair value ($2.52). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: ADAG is 12.9% above fair value ($2.52). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: ADAG is currently trading at $2.85, which is considered extended relative to its 30-day fair value range of $1.62 to $2.52.
Technical Outlook: Technically, ADAG is showing sideways momentum. Immediate support is located at $1.69, while resistance sits at $3.19. Short-term momentum is weak, with the stock down 3.2% recently.
Market Sentiment: ADAG has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $9.51 (+223.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ADAG is showing sideways momentum. Immediate support is located at $1.69, while resistance sits at $3.19. Short-term momentum is weak, with the stock down 3.2% recently.
Market Sentiment: ADAG has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $9.51 (+223.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$1.62 -
$2.52
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
47.4%
All Signals
- BEARISH: Price significantly overextended (+12.9% above fair value)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.2%)
- BULLISH: Trading 223.6% below Wall St target ($9.51)
Fair Price Analysis
30-Day Fair Range
$1.62 -
$2.52
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$1.69
Resistance Level
$3.19
Current Trend
Sideways
Fundamental Context
Forward P/E (Next Year Est.)
-4.08
Wall Street Target
$9.51
(+223.6%)
Revenue Growth (YoY)
-87.3%
Last updated: February 03, 2026 1:23 PM ET
Data refreshes hourly during market hours. Next update: 2:23 PM
Data refreshes hourly during market hours. Next update: 2:23 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ADAG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$112 | 57 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$93 | 59 HOLD |
|
RNA
Avidity Biosciences Inc |
STRONG BUY
15 analysts |
$75 | 59 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$34 | 57 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$108 | 60 HOLD |
